U.S. regulators have authorized a second booster dose of Pfizer Inc and BioNTech SE's COVID-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3